Found: 35
Select item for more details and to access through your institution.
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1378, doi. 10.1002/cpt.2267
- Publication type:
- Article
Effect of Corticosteroids on Mortality in Hospitalized COVID‐19 Patients Not Receiving Invasive Mechanical Ventilation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1660, doi. 10.1002/cpt.2245
- By:
- Publication type:
- Article
The Uncertainties of Metamizole Use.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1373, doi. 10.1002/cpt.2258
- By:
- Publication type:
- Article
Impact of Acute Inflammation on Cytochromes P450 Activity Assessed by the Geneva Cocktail.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1668, doi. 10.1002/cpt.2146
- By:
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1376, doi. 10.1002/cpt.2250
- Publication type:
- Article
CORRIGENDUM: DNL104, a Centrally Penetrant RIPK1 Inhibitor, Inhibits RIP1 Kinase Phosphorylation in a Randomized Phase I Ascending Dose Study in Healthy Volunteers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1678, doi. 10.1002/cpt.2242
- Publication type:
- Article
COVID‐19 and the Emerging Regulatory Guidance for Ongoing Clinical Trials in the European Union.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1517, doi. 10.1002/cpt.2225
- By:
- Publication type:
- Article
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1371, doi. 10.1002/cpt.2257
- Publication type:
- Article
Corrigendum: Drug‐Related Hospitalization at a Tertiary Teaching Center in Lebanon: Incidence, Associations, and Relation to Self‐Medicating Behavior.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1677, doi. 10.1002/cpt.2211
- Publication type:
- Article
A Multipurpose First‐in‐Human Study With the Novel CXCR7 Antagonist ACT‐1004‐1239 Using CXCL12 Plasma Concentrations as Target Engagement Biomarker.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1648, doi. 10.1002/cpt.2154
- By:
- Publication type:
- Article
Tribute: Sir Colin Terence Dollery, MB, Ch, MD (Hon).
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1388, doi. 10.1002/cpt.2150
- By:
- Publication type:
- Article
Real‐World Infliximab Pharmacokinetic Study Informs an Electronic Health Record‐Embedded Dashboard to Guide Precision Dosing in Children with Crohn's Disease.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1639, doi. 10.1002/cpt.2148
- By:
- Publication type:
- Article
Reapproaching Old Treatments: Considerations for PK/PD Studies on Phage Therapy for Bacterial Respiratory Infections.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1443, doi. 10.1002/cpt.2214
- By:
- Publication type:
- Article
Individual Atrasentan Exposure is Associated With Long‐term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1631, doi. 10.1002/cpt.2143
- By:
- Publication type:
- Article
Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1505, doi. 10.1002/cpt.2141
- By:
- Publication type:
- Article
Impact of Hepatic CYP3A4 Ontogeny Functions on Drug–Drug Interaction Risk in Pediatric Physiologically‐Based Pharmacokinetic/Pharmacodynamic Modeling: Critical Literature Review and Ivabradine Case Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1618, doi. 10.1002/cpt.2134
- By:
- Publication type:
- Article
Utility of Normalized TdP Score System in Drug Proarrhythmic Potential Assessment: A Blinded in vitro Study of CiPA Drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1606, doi. 10.1002/cpt.2133
- By:
- Publication type:
- Article
Thromboembolic and Hemorrhagic Outcomes in the Direct Oral Anticoagulant Trials Across the Spectrum of Kidney Function.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1593, doi. 10.1002/cpt.2131
- By:
- Publication type:
- Article
Characterizing Effects of Antidiabetic Drugs on Heart Rate, Systolic and Diastolic Blood Pressure.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1583, doi. 10.1002/cpt.2130
- By:
- Publication type:
- Article
Experimental Medicine Study to Measure Immune Checkpoint Receptors PD‐1 and GITR Turnover Rates In Vivo in Humans.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1575, doi. 10.1002/cpt.2129
- By:
- Publication type:
- Article
Developing and Validating a Clinical Warfarin Dose‐Initiation Model for Black‐African Patients in South Africa and Uganda.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1564, doi. 10.1002/cpt.2128
- By:
- Publication type:
- Article
Pharmacogenetics at Scale: An Analysis of the UK Biobank.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1528, doi. 10.1002/cpt.2122
- By:
- Publication type:
- Article
Détente: A Practical Understanding of P values and Bayesian Posterior Probabilities.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1489, doi. 10.1002/cpt.2004
- By:
- Publication type:
- Article
Points to Consider for Implementation of the ICH E17 Guideline: Learning from Past Multiregional Clinical Trials in Japan.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1555, doi. 10.1002/cpt.2121
- By:
- Publication type:
- Article
Effects of NT5C2 Germline Variants on 6‐Mecaptopurine Metabolism in Children With Acute Lymphoblastic Leukemia.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1538, doi. 10.1002/cpt.2095
- By:
- Publication type:
- Article
Circadian Variation in Efficacy of Medications.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1457, doi. 10.1002/cpt.2073
- By:
- Publication type:
- Article
Transdermal Testosterone Attenuates Drug‐Induced Lengthening of Both Early and Late Ventricular Repolarization in Older Men.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1499, doi. 10.1002/cpt.2072
- By:
- Publication type:
- Article
Keeping the Pharmacology in Pharmacoepidemiology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1393, doi. 10.1002/cpt.2006
- By:
- Publication type:
- Article
Differential Effects of Clopidogrel With or Without Aspirin on Platelet Reactivity and Coagulation Activation: A Randomized Trial in Healthy Volunteers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1546, doi. 10.1002/cpt.2106
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1363, doi. 10.1002/cpt.1900
- Publication type:
- Article
Farewell to our Wonderful Friend and Colleague, J. Richard (Dick) Crout (1929–2020).
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1384, doi. 10.1002/cpt.2063
- By:
- Publication type:
- Article
Postmarket Safety Communication for Protection of Public Health: A Comparison of Regulatory Policy in Australia, Canada, the European Union, and the United States.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1424, doi. 10.1002/cpt.2010
- By:
- Publication type:
- Article
COVID‐19: A Catalyst to Accelerate Global Regulatory Transformation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1390, doi. 10.1002/cpt.2046
- By:
- Publication type:
- Article
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1417, doi. 10.1002/cpt.2015
- By:
- Publication type:
- Article
Strategies and Recommendations for Using a Data‐Driven and Risk‐Based Approach in the Selection of First‐in‐Human Starting Dose: An International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) Assessment.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1395, doi. 10.1002/cpt.2009
- By:
- Publication type:
- Article